These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18687136)

  • 1. Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines.
    Cody NA; Zietarska M; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    BMC Med Genomics; 2008 Aug; 1():34. PubMed ID: 18687136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
    Presneau N; Mes-Masson AM; Ge B; Provencher D; Hudson TJ; Tonin PN
    Oncogene; 2003 Mar; 22(10):1568-79. PubMed ID: 12629520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
    Birch AH; Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2008 Jan; 47(1):56-65. PubMed ID: 17620309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.
    Manderson EN; Mes-Masson AM; Novak J; Lee PD; Provencher D; Hudson TJ; Tonin PN
    Genome Res; 2002 Jan; 12(1):112-21. PubMed ID: 11779836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).
    Zietarska M; Maugard CM; Filali-Mouhim A; Alam-Fahmy M; Tonin PN; Provencher DM; Mes-Masson AM
    Mol Carcinog; 2007 Oct; 46(10):872-85. PubMed ID: 17455221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.
    Manderson EN; Birch AH; Shen Z; Mes-Masson AM; Provencher D; Tonin PN
    Int J Gynecol Cancer; 2009 May; 19(4):513-25. PubMed ID: 19509545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.
    Tonin PN; Hudson TJ; Rodier F; Bossolasco M; Lee PD; Novak J; Manderson EN; Provencher D; Mes-Masson AM
    Oncogene; 2001 Oct; 20(45):6617-26. PubMed ID: 11641787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes.
    Wojnarowicz PM; Breznan A; Arcand SL; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Int J Gynecol Cancer; 2008; 18(5):963-75. PubMed ID: 18028382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation.
    de Lima AB; Silva LM; Gonçales NG; Carvalho MRS; da Silva Filho AL; da Conceição Braga L
    Cancer Microenviron; 2018 Jun; 11(1):85-92. PubMed ID: 29307001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
    Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP-2 signaling in ovarian cancer and its association with poor prognosis.
    Le Page C; Puiffe ML; Meunier L; Zietarska M; de Ladurantaye M; Tonin PN; Provencher D; Mes-Masson AM
    J Ovarian Res; 2009 Apr; 2():4. PubMed ID: 19366455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A.
    Samouëlian V; Maugard CM; Jolicoeur M; Bertrand R; Arcand SL; Tonin PN; Provencher DM; Mes-Masson AM
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):497-504. PubMed ID: 15258697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
    Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
    Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of three new serous epithelial ovarian cancer cell lines.
    Ouellet V; Zietarska M; Portelance L; Lafontaine J; Madore J; Puiffe ML; Arcand SL; Shen Z; Hébert J; Tonin PN; Provencher DM; Mes-Masson AM
    BMC Cancer; 2008 May; 8():152. PubMed ID: 18507860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling of ovarian cancer models using TMT-LC-MS/MS.
    Sinclair J; Timms JF
    Methods Mol Biol; 2013; 1049():271-84. PubMed ID: 23913223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin I mRNA expression correlates with kinase insert domain receptor expression in human epithelial ovarian cancer.
    Cybulski M; Jeleniewicz W; Nowakowski A; Stenzel-Bembenek A; Tarkowski R; Kotarski J; Stepulak A
    Anticancer Res; 2015 Feb; 35(2):1115-9. PubMed ID: 25667501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro model.
    Meunier L; Puiffe ML; Le Page C; Filali-Mouhim A; Chevrette M; Tonin PN; Provencher DM; Mes-Masson AM
    Transl Oncol; 2010 Aug; 3(4):230-8. PubMed ID: 20689764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.
    Gambaro K; Quinn MC; Cáceres-Gorriti KY; Shapiro RS; Provencher D; Rahimi K; Mes-Masson AM; Tonin PN
    BMC Cancer; 2015 Mar; 15():135. PubMed ID: 25886299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A useful cell system for studying the regulation of 17HSD/KSR type 2 activity and expression in ovarian epithelial cancer.
    Provost PR; Lima PH; Tremblay Y; Blomquist CH
    J Steroid Biochem Mol Biol; 2010 Oct; 122(4):295-301. PubMed ID: 20600897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitor SERPINA1 expression in epithelial ovarian cancer.
    Normandin K; Péant B; Le Page C; de Ladurantaye M; Ouellet V; Tonin PN; Provencher DM; Mes-Masson AM
    Clin Exp Metastasis; 2010; 27(1):55-69. PubMed ID: 20049513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.